ADARx Pharmaceuticals raises $446.3 million in U.S. IPO
Biotech listings continue to draw investor demand in the U.S. IPO market, with ADARx Pharmaceuticals pricing an enlarged share sale at the top of its marketed range. The San Diego drug developer ...